Most patients with bony metastases experience painful symptoms. Strontium-89 isotope therapy is an alternative to traditional hemibody radiation in cases of multiple, diffuse metastases. Generally given as a single IV slow-push infusion, relief begins in one to three weeks, peaks at six weeks, and has a mean duration of 12 months. Up to 22 percent of patients are pain-free at three months.
Get full access to this article
View all access options for this article.
References
1.
Robinson RG, et al: Clinical experience with Strontium-89 in prostatic and breast cancer patients. Semin Oncol. 1993;20:44-48.
2.
Clinical Practice Guideline Number 9—Management of Cancer Pain. US Dept of Health and Human Services, 1994.
3.
Patt RB: Cancer Pain. Philadelphia, J.B. Lippincott, 1993; 465.
4.
Salazar OM: Single dose half-body irradiation for palliation of multiple bone metastases from solid tumors. Cancer. 1986;58:29-36.
5.
Bolger JJ, et al: Strontium-89 Versus External Beam Radiotherapy in Patients with Painful Bone Metastases Secondary to Prostatic Cancer: Preliminary Report of a Multicenter Trial. Semin Oncol. 1993;20(3): 32-33(suppl 2).
6.
Doyle D, et al: Oxford Textbook of Palliative Medicine. Oxford, Great Britain, Oxford University Press, 1993; 119.
7.
Porter AT, et al: Results of a randomized phase-III trial to evaluate the efficacy of Strontium-89 adjuvant to local field external beam irradiation in the management of endocrine resistant metastatic prostate cancer. Int J Radiat Oncol Bil Phys. 1993;25:805-813.
8.
Garret I: Bone Destruction in Cancer. Semin Oncol. 1993;20(3): 4-9(suppl 2).
9.
Orr J, et al: Chemotactic responses to tumor cells to products of resorbing bone. Science. 1979;203:176-179.
10.
Mertens WC, et al: Strontium 89 Therapy and Relief of Pain in Patients with Prostatic Carcinoma Metastatic to Bone: A Dose Response Relationship?Am J Clin Oncol. 1993;16(3): 238-242.
11.
Mertens WC, et al: Recent Advances in Radionuclide therapy of bone metastases. Nuclear Medicine Annual 1992. Raven. 1992; 69-89.
12.
Robinson RG, et al: Treatment of Metastatic Bone Pain with Strontium-89. Nucl Med Biol. 1987;14:219-222.
13.
Holmes RA: Radiopharmaceuticals in Clinical Trials. Semin Oncol. 1993;20(3): 22-26.
14.
Laing AH, et al: Strontium-89 Chloride for Pain Palliation in Prostatic Skeletal Malignancy. Br J Radiol. 1991;64:816-822.
15.
Medical Letter on Drugs and Therapeutics. 1993; 35(908): 102.
16.
Hansen DV, et al: Strontium-89 Therapy for Painful Osseous Metastatic Prostate and Breast Cancer. Amer Fam Phys. 1993;47(8): 1795-1800.
